Antibiotic label claim

KVH continues to work with Zespri and ACVM to confirm label claims and use conditions for KeyStrepto™ and Kasumin® post 15 June 2014. Currently both products cannot be used before 15 June unless a Justified Approval (JA) is issued by Zespri, and only under extenuating circumstances.

Unless we receive confirmation from ACVM as to the use condition, this date is likely to be extended.

KVH will advise growers of progress through the KVH Bulletin.